Triton Wealth Management, Pllc Harvard Bioscience Inc Transaction History
Triton Wealth Management, Pllc
- $166 Million
- Q2 2024
A detailed history of Triton Wealth Management, Pllc transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Triton Wealth Management, Pllc holds 13,413 shares of HBIO stock, worth $34,069. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,413
Previous 13,413
-0.0%
Holding current value
$34,069
Previous $56,000
32.14%
% of portfolio
0.02%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding HBIO
# of Institutions
102Shares Held
32MCall Options Held
1.2KPut Options Held
1.2K-
Black Rock Inc. New York, NY2.84MShares$7.22 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$7.04 Million0.49% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.56MShares$6.5 Million0.9% of portfolio
-
Amh Equity LTD2.2MShares$5.59 Million8.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$5.38 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $106M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...